Pfizer to pay $2.26 billion for cancer treatment developer Trillium

Pfizer to pay $2.26 billion for cancer treatment developer Trillium Cancer treatments brought in $10.9 billion in revenue last year, and Pfizer’s oncology products include treatments for breast, colorectal, blood and lung cancers.

No comments:

Post a Comment